Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jun 2017 14:31

RNS Number : 5776H
Caledonia Investments PLC
08 June 2017
Β 

Caledonia Investments plc

Director/PDMR Shareholding Notification

Β 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulations of the following transactions involving three of its directors, Jamie Cayzer-Colvin, Stephen King and William Wyatt as detailed below.

Β 

On 6 June 2017, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") and 2011 Performance Share Scheme ("Performance Share Scheme"), at nil cost. On the same date, Mr Cayzer-Colvin exercised options under Caledonia's 2005 Executive Share Option Scheme ("Executive Share Option Scheme") at an exercise price of 1446p. All resulting shares were sourced from the Caledonia Investments plc Employee Share Trust and subsequently sold at 2910p per share on the same date.

Β 

Deferred Bonus Plan

No of shares transferred under the Deferred Bonus Plan at Β£nil

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

Β 

11,302

0.02

11,302

SA King

13,365

0.02

13,365

WP Wyatt

Β 

18,837

0.03

18,837

Β 

Performance Share Scheme

No of shares transferred under the Performance Share Scheme at Β£nil

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

Β 

19,749

0.04

19,749

SA King

11,194

0.02

11,194

WP Wyatt

Β 

15,776

0.03

15,776

Β 

Β 

Executive Share Option Scheme

No of options exercised under the Executive Share Option Scheme at 1446p

Β 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

12,707

0.02

12,707

Β 

Further information required by the EU Market Abuse Regulations in relation to these transactions is set out in the appendix below.

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 June 2017

Β 

APPENDIXΒ 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Exercise of options with an exercise price of Β£14.46

3. Call of Deferred Bonus Plan ("DBP") awards

4. Sale of all shares

Β 

Β 

c)

Β 

Β 

Β 

Price(s) and volume(s)

Β 

Β 

1. Exercise of PSS awards

Β 

2. Exercise of options

Β 

3. Call of DBP awards

Β 

4. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

19,749

Β 

Β£14.46

12,707

Β£0.00

11,302

Β£29.10

43,758

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

Β 

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Exercise of PSS awards, exercise of options with an exercise price of Β£14.46 and call of DBP awards: 43,758

Β 

Sale of shares: 43,758

Β 

Exercise of PSS awards (Β£nil), exercise of options with an exercise price of Β£14.46 (Β£14.46) and call of DBP awards (Β£nil): weighted average price Β£4.20

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards, options with an exercise price of Β£14.46 and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stephen Anthony King

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

Β 

Β 

Price(s) and volume(s)

Β 

Β 

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

11,194

Β 

Β£0.00

13,365

Β£29.10

24,559

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

Β 

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Exercise of PSS awards and call of DBP awards: 24,559

Β 

Sale of shares: 24,559

Β 

Exercise of PSS awards and call of deferred shares: Β£nil

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Β 

Sale of shares - London Stock Exchange XLON

Β 

Β 

Β 

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

Β 

c)

Β 

Β 

Price(s) and volume(s)

Β 

1. Exercise of PSS awards

Β 

2. Call of DBP awards

Β 

3. Sale of shares

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

15,776

Β 

Β£0.00

18,837

Β£29.10

34,613

Β 

Β 

Β 

Β 

Β 

d)

Β 

Β 

Β 

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Β 

Exercise of PSS awards and call of DBP awards: 34,613

Β 

Sale of shares: 34,613

Β 

Β 

Exercise of PSS awards and call of deferred shares: Β£nil

Β 

Sale of shares: Β£29.10

Β 

e)

Β 

Date of the transaction

Β 

Β 

6 June 2017

f)

Β 

Place of the transaction

Β 

Β 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Β 

Sale of shares - London Stock Exchange XLON

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSSUFDAFWSEEM
Date   Source Headline
8th Jan 201910:02 amRNSReport for the quarter ended 31 December 2018
8th Jan 201910:00 amRNSNet Asset Value(s)
2nd Jan 20198:31 amRNSBlock listing Interim Review
21st Dec 20189:04 amRNSAcquisition
19th Dec 201810:40 amRNSReclassification of AIC sector
19th Dec 20188:28 amRNSHalf-year Report
6th Dec 20189:47 amRNSNet Asset Value(s)
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:45 pmRNSDirector Declaration
15th Nov 20187:00 amRNSDirectorate Change
7th Nov 20189:09 amRNSNet Asset Value(s)
23rd Oct 20187:48 amRNSDisposal
15th Oct 20187:00 amRNSAcquisition
4th Oct 20181:57 pmRNSNet Asset Value(s)
6th Sep 20189:41 amRNSNet Asset Value(s)
1st Aug 20181:43 pmRNSPortfolio Update
19th Jul 201812:52 pmRNSResult of AGM
16th Jul 201811:28 amRNSDirectorate Change
13th Jul 20187:49 amRNSAcquisition
6th Jul 201810:34 amRNSReport for the quarter ended 30 June 2018
6th Jul 201810:31 amRNSNet Asset Value(s)
2nd Jul 20188:35 amRNSBlock listing Interim Review
28th Jun 201811:34 amRNSHolding(s) in Company
19th Jun 20189:12 amRNSAnnual Financial Report
6th Jun 201812:47 pmRNSNet Asset Value(s)
31st May 20185:11 pmRNSTotal Voting Rights
31st May 20183:00 pmRNSDirector/PDMR Shareholding
31st May 20189:17 amRNSDirector/PDMR Shareholding
25th May 20185:02 pmRNSTransaction in Own Shares
24th May 20185:11 pmRNSFinal Results - Correction
24th May 20187:00 amRNSFinal Results
4th May 201810:31 amRNSNet Asset Value(s)
13th Apr 20184:31 pmRNSHolding(s) in Company
9th Apr 201811:51 amRNSNet Asset Value(s)
29th Mar 20183:33 pmRNSTransaction in Own Shares
6th Mar 201810:03 amRNSNet Asset Value(s)
15th Feb 20183:14 pmRNSDirector/PDMR Shareholding
6th Feb 20181:14 pmRNSNet Asset Value(s)
8th Jan 201812:31 pmRNSDirector/PDMR Shareholding
5th Jan 20181:24 pmRNSReport for the quarter ended 31 Dec 2017
5th Jan 20181:19 pmRNSNet Asset Value(s)
2nd Jan 20189:49 amRNSBlock listing Interim Review
20th Dec 201710:44 amRNSDirector/PDMR Shareholding
12th Dec 20178:57 amRNSHalf-year Report
6th Dec 201712:20 pmRNSNet Asset Value(s)
30th Nov 20175:29 pmRNSDirector/PDMR Shareholding
30th Nov 201711:39 amRNSDirectorate Change
23rd Nov 20177:00 amRNSHalf-year Report
6th Nov 20173:23 pmRNSNet Asset Value(s)
1st Nov 20179:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.